Jeff Ajer

EVP & Chief Commercial Officer at BioMarin Pharmaceutical

Jeff Ajer joined BioMarin in August 2005 and currently serves as the Executive Vice President and Chief Commercial Officer. From October 2012 to January 2014, Mr. Ajer served as the Senior Vice President and Chief Commercial Officer. From April 2009 to October 2012, Mr. Ajer served as the Vice President, Commercial Operations, The Americas, where he had responsibility for commercial operations throughout the Americas and led product marketing, reimbursement, and sales operations for BioMarin. Prior to joining BioMarin, Mr. Ajer served in various roles at Genzyme Corporation (Genzyme) beginning in November 2003, most recently as Vice President, Global Transplant Operations from December 2004 to August 2005. Mr. Ajer’s experience prior to Genzyme includes roles in sales, marketing and operations at SangStat Medical Corporation and ICN Pharmaceuticals. Mr. Ajer received both a B.S. in chemistry and an M.B.A. from the University of California, Irvine. Mr. Ajer is currently a director of Nektar Therapeutics, a public biopharmaceutical company.

Links

Timeline

  • EVP & Chief Commercial Officer

    Current role

View in org chart